Aion Therapeutic Inc.
Aion Therapeutic Inc. (ANTCF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
antcf · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Aion Therapeutic Inc.You ANTCF | $2M | N/A | — | — |
 Bhang Inc. BHNGF | $0M | N/A | — | -$0.02 |
 CannaPharmaRX, Inc. CPMD | $1M | N/A | — | -$0.02 |
 EVIO, Inc. EVIO | $2M | 3.34x | — | $0.00 |
 FutureWorld Corp. FWDG | $0M | N/A | — | -$0.00 |
 Hemp, Inc HEMP | $1M | N/A | — | -$0.00 |
 James E. Wagner Cultivation Corporation JWCAF | $0M | N/A | — | -$0.08 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Aion Therapeutic Inc. (ANTCF) measures how much investors pay for each dollar of the company's trailing earnings. ANTCF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of —.
Frequently asked questions
ANTCF pe ratio · 6 questionsANTCF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of —. Data sourced from Financial Modeling Prep via ANTCF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Aion Therapeutic Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09